1 Under The Radar Stock to Buy Before It Explodes!

In this video, I will be talking about Vikings Therapeutics, VKTX stock.
👉A portion of this video is sponsored by The Motley Fool.

WATCH NEXT:

Don't forget to do your own research before buying into a stock!

DISCLAIMER: I do not provide personal investment advice and I am not a qualified licensed investment advisor. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment, or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. I will not and cannot be held liable for any actions you take as a result of anything you read and/or view here. #investing #vktx

[matthewogradymusic]

Bought 2k worth at $8. It’s worth almost 9k now Had it up to around 18k for a time but then dipped. I’m a strong hold. Merck is considered a strong contender to buy them up and that would bring it back to the 80- 90 a share range.

[johnkess]

I own some VKTX as a speculative holding. The Phase II results are very promising. We shall see. I also own some HUMA, which has an off-the-shelf, bioengineered blood vessel that was recently approved by the FDA as an alternative to vein grafting.

[roark-]

@Couch -- A month later and now it's sitting at ~30. Opened a position. Definitely the most speculative thing I own.

I always enjoy your videos, Neil. They are very comprehensive and well thought out. I do think these GLP markets are getting crowded. I know that Pfizer is working on an oral one as well. The oral agents have to be taken daily on an empty stomach and you can’t have anything for 30 to 60 minutes after taking them in the morning. This includes even coffee, which would be a no deal for me. The injectables can be given once a week without that restriction. Just saying.

[tmad]

First time investing in biotech last summer and I got burned holding past the runup to Obesity Week on this one. Didn't realize how short-lived pops from catalysts can be on these things. Hoping catalysts this year can base this ticker higher. DCA feels bad because there is really no bottom with these speculative biotechs. Hoping for the best at JPM.

I always enjoy your videos. They are very comprehensive and well thought out. I do feel that the Gill PL market is getting quite crowded. I also know that Pfizer is also working on an oral agent. I do know that the oral agents have to be taken on an empty stomach and 30 to 60 minutes before you can consume anything including coffee. This would be a dealbreaker for me. Just saying.

[nattydred]

The big thing to look for is projected spending, cash runway. Things can look rosey, and then the FDA wants more data, and that could take another 18 months.

[fredericjanelle]

Vikins Therapeutics has only 27 employees... how is that possible with a market cap of close to 5 billions?

[rg]

I don't know if this is a good company or not, but I do have some experience in the space, and the numbers to get a product to market are sobering, and not to be dismissed.

For example, just to set up a lab - $250M isn't a crazy number. Bring a drug to market - $1B. Time to bring a product that requires FDA approval to market - 10 years.

Most of these companies are acquisition candidates, but only if they have a real product.

Obesity drugs = AI fluff right now. Yes, they might be a winner, there's no way to know until the test group results come in. MOST are misses.

[Successpockets]

It’s gonna be hard to compete with ozempic. It’s like Coca Cola vs a beverage stock pre revenue

Sorry, First time posting. And I accidentally put the same message on three times so enjoy it from the Department of redundancy department

[Tranhuythinh]

Can you do a video about Recursion Pharmaceuticals stock

[TC.C]

I’ve bought 2 therapeutic stocks before like this one, one I made a handsome profit whilst the other dropped 60% and I’m still holding. I learned a lot from it 😊

[NathanXSavage]

Rather just buy HIMS if you wanted to play this industry, that's my opinion.

[TheMisteryFrancisco]

In the field of oral glp1 inhibitor, what you think about LEXX and ALT?

[MYlifeAScrazy]

Selling some puts here is a great entry. If you do a NPV of VKTX you get to something like a $200 stock here today. 4.5 billion market cap is revenue they can have in 1 qaurter in the future, espescially for there oral drug. Like you said make it a small portiin of the portfolio but I think there is def some great assymetric risk here.

[jamessaintjames]

I've had my eye on viking for a few months but it fell somewhat.

If it is a choice between this, NU, NVO or MELI which would you buy with your name few 1000 USDs?